Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
Purpose
This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a dose-finding study for CSL300 vs placebo. Part 2 (phase 3) aims to assess the efficacy of CSL300 on cardiovascular (CV) outcomes and safety in subjects with systemic inflammation and either atherosclerotic cardiovascular disease (ASCVD) or diabetes with end stage kidney disease (ESKD) undergoing maintenance dialysis.
Conditions
- Atherosclerotic Cardiovascular Disease
- End Stage Kidney Disease
- Atherosclerotic Cardiovascular Disease in Patients With ESKD
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Male or female at least 18 years of age - A diagnosis of ESKD undergoing maintenance dialysis for at least 12 weeks - Serum hs-CRP ≥ 2.0 mg/L - A diagnosis of diabetes mellitus OR ASCVD
Exclusion Criteria
- Subjects who participated in Part 1 (phase 2b) are not eligible to participate in Part 2 (phase 3) - Concomitant use of systemic immunosuppressant drugs - Abnormal LFTs - Any life-threatening disease expected to result in death within 12 months - A history of GI perforation, inflammatory bowel disease (except fully excised ulcerative colitis), or peptic ulcer disease - Clinically significant active infection or history of opportunistic or invasive fungal infection
Study Design
- Phase
- Phase 2/Phase 3
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Supportive Care
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Experimental CSL300 (low dose)(Phase 2b) |
Intravenous (IV) administration |
|
Experimental CSL300 (medium dose)(Phase 2b) |
IV administration |
|
Experimental CSL300 (high dose)(Phase 2b) |
IV administration |
|
Placebo Comparator Placebo (Phase 2b) |
IV administration |
|
Experimental CSL300 (Phase 3) |
IV administration |
|
Placebo Comparator Placebo (Phase 3) |
IV administration |
|
Recruiting Locations
Huntsville, Alabama 35805
Use Central Contact
Montgomery, Alabama 36117
Use Central Contact
Glendale, Arizona 85305
Use Central Contact
Glendale, Arizona 91206
Use Central Contact
Phoenix, Arizona 85018
Use Central Contact
Tucson, Arizona 85705
Use Central Contact
Bakersfield, California 93309
Use Central Contact
Bakersfield, California 93309
Use Central Contact
Beverly Hills, California 90211
Use Central Contact
Chula Vista, California 91910
Use Central Contact
Fullerton, California 92832
Use Central Contact
Fullerton, California 92835
Use Central Contact
Garden Grove, California 92843
Use Central Contact
Garden Grove, California 92843
Use Central Contact
Garden Grove, California 92844
Use Central Contact
Glendale, California 91204
Use Central Contact
Glendale, California 91206
Use Central Contact
Granada Hills, California 91344
Use Central Contact
La Mesa, California 91942
Use Central Contact
La Mesa, California 91942
Use Central Contact
La Palma, California 90623
Use Central Contact
La Palma, California 90623
Use Central Contact
Los Angeles, California 90022
Use Central Contact
Los Angeles, California 90027
Use Central Contact
Lynwood, California 90262
Use Central Contact
Northridge, California 91324
Use Central Contact
Oxnard, California 93036
Use Central Contact
Riverside, California 92504
Use Central Contact
Riverside, California 92505
Use Central Contact
Salinas, California 93901
Use Central Contact
San Diego, California 92111
Use Central Contact
San Dimas, California 91773
Use Central Contact
San Dimas, California 91773
Use Central Contact
Tarzana, California 91356
Use Central Contact
Vacaville, California 95687
Use Central Contact
Victorville, California 92392
Use Central Contact
Victorville, California 92394
Use Central Contact
Denver, Colorado 80210
Use Central Contact
Denver, Colorado 80230
Use Central Contact
Bloomfield, Connecticut 06002
Use Central Contact
Middlebury, Connecticut 06762
Use Central Contact
Newark, Delaware 19713
Use Central Contact
Boca Raton, Florida 33431
Use Central Contact
Coral Gables, Florida 33134
Use Central Contact
Coral Springs, Florida 33071
Use Central Contact
Hialeah Gardens, Florida 33016
Use Central Contact
Hollywood, Florida 33024
Use Central Contact
Lauderdale Lakes, Florida 33313
Use Central Contact
Medley, Florida 33166
Use Central Contact
Miami Lakes, Florida 33016
Use Central Contact
Miami, Florida 33126
Use Central Contact
Miami, Florida 33150
Use Central Contact
Miami, Florida 33173
Use Central Contact
Orlando, Florida 32806
Use Central Contact
Temple Terrace, Florida 33637
Use Central Contact
Winter Park, Florida 32789
Use Central Contact
Brunswick, Georgia 31520
Use Central Contact
Columbus, Georgia 31904
Use Central Contact
Douglasville, Georgia 30101
Use Central Location
Mishawaka, Indiana 46545
Use Central Contact
Sioux City, Iowa 57049
Use Central Contact
Wichita, Kansas 67214
Use Central Contact
Louisville, Kentucky 40205
Use Central Contact
Baton Rouge, Louisiana 70808
Use Central Contact
Kalamazoo, Michigan 49007
Use Central Contact
Pontiac, Michigan 48341
Use Central Contact
Roseville, Michigan 48066
Use Central Contact
Saint Clair Shores, Michigan 48081
Use Central Contact
Minneapolis, Minnesota 55404
Use Central Contact
Columbus, Mississippi 39705
Use Central Contact
Tupelo, Mississippi 38801
Use Central Contact
Kansas City, Missouri 64111
Use Central Contact
Lincoln, Nebraska 68510
Use Central Contact
North Platte, Nebraska 69101
Use Central Contact
Henderson, Nevada 89074
Use Central Contact
Las Vegas, Nevada 89106
Use Central Contact
Reno, Nevada 89511
Use Central Contact
Portsmouth, New Hampshire 03801
Use Central Contact
Eatontown, New Jersey 07724
Use Central Contact
Jersey City, New Jersey 07305
Use Central Contact
Bronx, New York 10467
Use Central Contact
College Point, New York 11356
Use Central Contact
Charlotte, North Carolina 28204
Use Central Contact
Durham, North Carolina 27704
Use Central Contact
Greenville, North Carolina 27858
Use Central Contact
Raleigh, North Carolina 27610
Use Central Location
Columbus, Ohio 43215
Use Central Contact
Bethlehem, Pennsylvania 18017
Use Central Contact
Columbia, South Carolina 29203
Use Central Contact
Spartanburg, South Carolina 29306
Use Central Contact
Knoxville, Tennessee 37923
Use Central Contact
Austin, Texas 78751
Use Central Contact
Austin, Texas 78758
Use Central Contact
Beaumont, Texas 77701
Use Central Contact
Dallas, Texas 75237
Use Central Contact
El Paso, Texas 79925
Use Central Contact
El Paso, Texas 79935
Use Central Contact
Fort Worth, Texas 76110
Use Central Contact
Houston, Texas 77054
Use Central Contact
Houston, Texas 77054
Use Central Contact
Houston, Texas 77058
Use Central Contact
Houston, Texas 77074
Use Central Contact
Houston, Texas 77090
Use Central Contact
Houston, Texas 77099
Use Central Contact
McAllen, Texas 78503
Use Central Location
San Antonio, Texas 78204
Use Central Contact
San Antonio, Texas 78229
Use Central Contact
San Antonio, Texas 78251
Use Central Contact
San Antonio, Texas 78258
Use Central Contact
Shenandoah, Texas 77384
Use Central Contact
Chesapeake, Virginia 23320
Use Central Contact
Fairfax, Virginia 22033
Use Central Contact
Hampton, Virginia 23666
Use Central Contact
Norfolk, Virginia 23502
Use Central Contact
Bluefield, West Virginia 24701
Use Central Contact
More Details
- NCT ID
- NCT05485961
- Status
- Recruiting
- Sponsor
- CSL Behring